Official UK procurement notice
Service agreement for the provision of toxicology laboratory services for ethylene glycol and methanol analysis
Authority: Somerset NHS Foundation Trust (Central government)
What is being bought
Published requirement descriptionThe Toxicology laboratory provides an urgent service for ethylene glycol or methanol analysis for the management of patients following known or suspected ingestion.
CPV: Pathology services
The lotProcurement structure
single lot · no lot value publishedLot #1Service agreement for the provision of toxicology laboratory services for ethylene…Awarded
Service agreement for the provision of toxicology laboratory services for ethylene glycol and methanol analysis.<br/>The Toxicology laboratory provides an urgent service for ethylene glycol or methanol analysis for the management of patients following known or suspected ingestion. <br/>This notice is an intention to award a contract under the most suitable provider process.<br/>The approximate lifetime value of the contract is £3000.00.<br/>This is a new service with a new provider.<br/>The dates between which the services are intended to be provided are between May 2026 and April 2028.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 14 Apr 2026, 11:17 BST
- Last source update
- 12 Jun 2026, 12:13 BST
- Authority reference
PATH020- FTS notice number
2026/S 000-055643- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0681baFind a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by midnight on 24 April 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR'.
Publisher note: This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.<br/><br/>The decision makers were: Service Manager for Pathology, Bereavement & Spiritual Care Services Clinical Support & Cancer Services Directorate.<br/><br/>No conflicts of interest were declared among decision makers.<br/><br/>The key criteria were weighted as follows:<br/>25% quality and Innovation<br/>20% Value<br/>20% Integration, Collaboration and Service Sustainability<br/>25% Improving access, reducing health inequalities and facilitating choice<br/>10% Social value<br/>The highest weightings have been applied to Quality and Innovation and Improving access, reducing health inequalities and facilitating choice as fast access to critical toxicology diagnostics is essential for this service. Value is important and faster results reduce the need for unnecessary antidote treatment or dialysis, which are high‑cost interventions.<br/><br/>The rationale for choosing the provider with reference to the key criteria:<br/>The supplier are the closest specialist toxicology provider capable of performing both methanol and ethylene glycol testing in‑house.<br/>Key benefits include:<br/>• Minimising transport time<br/>• Reducing delays in diagnosis<br/>• Ensuring urgent samples can be processed rapidly<br/>• Providing direct access to specialist advice<br/>By using this supplier patients in Somerset benefit from faster, reliable access to critical toxicology diagnostics.
Notice history
2 releases on Find a TenderPublished amendments (1)
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally awarded using the most suitable provider process.The contract w…
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| NORTH BRISTOL NHS TRUST | £3,000 † | — | Awarded |
Contracts
Contract 033652-2026-1 · NORTH BRISTOL NHS TRUST
- Signed
- 13 Apr 2026
- Value
- £3,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- NHS EnglandMediation body
Bidders & participating suppliers
1 commercial party on the notice- NORTH BRISTOL NHS TRUSTAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.